{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:52Z","timestamp":1772121712421,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001342","name":"Republic of South Africa Department of Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.053","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:46:31Z","timestamp":1630482391000},"page":"5845-5853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response"],"prefix":"10.1016","volume":"39","author":[{"given":"James M.","family":"Azam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Saitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet R.C.","family":"Pulliam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7804","key":"10.1016\/j.vaccine.2021.08.053_b0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/d41586-020-01011-6","article-title":"Why measles deaths are surging \u2014 and coronavirus could make it worse","volume":"580","author":"Roberts","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.08.053_b0010","doi-asserted-by":"crossref","unstructured":"World Health Organization, WHO, World Health Organization. Measles vaccines: WHO position paper, April 2017 - Recommendations. Vaccine 2017;37:205\u201327. https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.066.","DOI":"10.1016\/j.vaccine.2017.07.066"},{"key":"10.1016\/j.vaccine.2021.08.053_b0015","doi-asserted-by":"crossref","unstructured":"Keating P, Isidro A, Martin C, Blake A, Lechevalier P, Uzzeni F, et al. Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province , Democratic Republic of Congo 2019:1\u201311.","DOI":"10.1186\/s12889-019-7500-z"},{"key":"10.1016\/j.vaccine.2021.08.053_b0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5588\/pha.13.0099","article-title":"Measles in the Democratic Republic of the Congo: an urgent wake-up call to adapt vaccination implementation strategies","volume":"4","author":"Gerard","year":"2014","journal-title":"Public Heal Action"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.053_b0025","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3390\/molecules24122217","article-title":"Continuous monitoring of shelf lives of materials by application of data loggers with implemented kinetic parameters","volume":"24","author":"Roduit","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2021.08.053_b0030","unstructured":"WHO. Guidelines on the stability evaluation of vaccines for use under extended controlled temperature conditions. WHO 2015:2268. https:\/\/doi.org\/WHO\/BS\/2015.2268."},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.053_b0035","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.vaccine.2020.02.005","article-title":"Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions","volume":"38","author":"Juan-Giner","year":"2020","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2021.08.053_b0045","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.vaccine.2014.01.038","article-title":"Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin","volume":"32","author":"Zipursky","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.053_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.13.123471","article-title":"Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad","volume":"92","author":"Lydon","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"28","key":"10.1016\/j.vaccine.2021.08.053_b0055","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1016\/j.vaccine.2016.03.080","article-title":"Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR","volume":"34","author":"Kolwaite","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.053_b0060","doi-asserted-by":"crossref","unstructured":"Patel MK, Kahn A. Comment Game changing\u00a0: hepatitis B vaccine in a controlled temperature chain. Lancet Glob Heal n.d.;6:e596--e597. https:\/\/doi.org\/10.1016\/S2214-109X(18)30233-X.","DOI":"10.1016\/S2214-109X(18)30233-X"},{"key":"10.1016\/j.vaccine.2021.08.053_b0065","unstructured":"World Health Organization, Controlled Temperature Chain Working Group. Controlled Temperature Chain: Strategic Roadmap for Priority Vaccines 2017-2020. Who\/Ivb\/1720 2017."},{"key":"10.1016\/j.vaccine.2021.08.053_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7189\/jogh.11.04004","article-title":"How the use of vaccines outside the cold chain or in controlled temperature chain contributes to improving immunization coverage in low- and middle-income countries (LMICs): A scoping review of the literature","volume":"11","author":"Dadari","year":"2021","journal-title":"J Glob Health"},{"issue":"18","key":"10.1016\/j.vaccine.2021.08.053_b0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1098\/rsif.2007.1038","article-title":"Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger","volume":"5","author":"Grais","year":"2008","journal-title":"J R Soc Interface"},{"issue":"1905","key":"10.1016\/j.vaccine.2021.08.053_b0080","doi-asserted-by":"crossref","first-page":"20190774","DOI":"10.1098\/rspb.2019.0774","article-title":"Concurrent assessment of epidemiological and operational uncertainties for optimal outbreak control: Ebola as a case study","volume":"286","author":"Li","year":"2019","journal-title":"Proc R Soc B Biol Sci"},{"key":"10.1016\/j.vaccine.2021.08.053_b0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pbio.1001970","article-title":"Adaptive management and the value of information: learning via intervention in epidemiology","volume":"12","author":"Shea","year":"2014","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.053_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1108\/JHLSCM-03-2017-0006","article-title":"Cold chains, interrupted: The use of technology and information for decisions that keep humanitarian vaccines cool","volume":"8","author":"Comes","year":"2018","journal-title":"J Humanit Logist Supply Chain Manag"},{"issue":"32","key":"10.1016\/j.vaccine.2021.08.053_b0095","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1016\/j.vaccine.2010.05.048","article-title":"Single versus multi-dose vaccine vials: An economic computational model","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.053_b0100","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.vaccine.2009.08.035","article-title":"Vaccine wastage in Bangladesh","volume":"28","author":"Guichard","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.053_b0105","article-title":"Management of a measles epidemic - a practical guide for doctors, nurses, laboratory technicians, medical auxilliaries and logisticians","author":"Danet","year":"2013","journal-title":"Medicins Sans Frontieres"},{"key":"10.1016\/j.vaccine.2021.08.053_b0110","doi-asserted-by":"crossref","unstructured":"Bj\u00f8rnstad ON. Epidemics. Model Data Using R Springer Int Publ 2018:318. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/978-3-319-97487-3.","DOI":"10.1007\/978-3-319-97487-3"},{"key":"10.1016\/j.vaccine.2021.08.053_b0115","first-page":"1","article-title":"PQS devices catalogue","author":"WHO","year":"2017","journal-title":"Who\/Ivb\/1108"},{"key":"10.1016\/j.vaccine.2021.08.053_b0120","doi-asserted-by":"crossref","unstructured":"Winter AK, Wesolowski AP, Mensah KJ, Bruna M, Randriamanantena AH, Cauchemez S, et al. Revealing Measles Outbreak Risk with a Nested IgG Serosurvey in Madagascar 2018. https:\/\/doi.org\/10.1093\/aje\/kwy114\/5033615.","DOI":"10.1093\/aje\/kwy114"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.053_b0125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1473-3099(17)30421-8","article-title":"Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis","volume":"17","author":"Trentini","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.053_b0130","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ejor.2018.05.054","article-title":"The benefits of combining early aspecific vaccination with later specific vaccination","volume":"271","author":"Duijzer","year":"2018","journal-title":"Eur J Oper Res"},{"key":"10.1016\/j.vaccine.2021.08.053_b0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/inthealth\/ihu062","article-title":"Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State","volume":"6","author":"Ferrari","year":"2014","journal-title":"Nigeria. Int Health"},{"key":"10.1016\/j.vaccine.2021.08.053_b0140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1017\/S0950268805005716","article-title":"Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics","volume":"134","author":"Grais","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.08.053_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tca.2014.01.005","article-title":"Prediction of thermal stability of materials by modified kinetic and model selection approaches based on limited amount of experimental points","volume":"579","author":"Roduit","year":"2014","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.vaccine.2021.08.053_b0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2018.01.005","article-title":"Accurate prediction of vaccine stability under real storage conditions and during temperature excursions","volume":"125","author":"Cl\u00e9net","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"7179","key":"10.1016\/j.vaccine.2021.08.053_b0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature06509","article-title":"The dynamics of measles in sub-Saharan Africa","volume":"451","author":"Ferrari","year":"2008","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:01:52Z","timestamp":1759402912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21011014"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.053","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.19.21257492","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}